Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1994; Volume 271,Issue 2
  • You have access
    Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
    M A Simmons, C R Schneider and J E Krause
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 581-589;
  • You have access
    Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons.
    B Yu and P Shinnick-Gallagher
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 590-600;
  • You have access
    Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
    E T Iwamoto and L Marion
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 601-608;
  • You have access
    Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
    A Asplund, D Grant and J O Karlsson
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 609-614;
  • You have access
    Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
    E W Jonsson and S E Dahlén
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 615-623;
  • You have access
    (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  • You have access
    Inhibition of K+ channels by chlorpromazine in rat ventricular myocytes.
    K Kon, E Krause and H Gögelein
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 632-637;
  • You have access
    Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    G Mittleman, A L Rosner and C L Schaub
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 638-650;
  • You have access
    Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function.
    X Yang and J J Buccafusco
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 651-659;
  • You have access
    Inhibition of nitric oxide synthase delays gastric emptying of solid meals.
    M Orihata and S K Sarna
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 660-670;
  • You have access
    Effects of estrogen on cardiovascular responses of premenopausal monkeys.
    J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  • You have access
    Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
    R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;
  • You have access
    Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    S M Evans, J R Troisi and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 683-694;
  • You have access
    The differential roles of sympathetic nerve activity in the pathogenesis of antral and corpus lesions induced by indomethacin in rats.
    K Kuratani, H Kodama and I Yamaguchi
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 695-702;
  • You have access
    Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.
    M Sugiura, Y Shoyama, H Saito and K Abe
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 703-707;
  • You have access
    Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
    J J McGuire, D J Anderson and B M Bennett
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 708-714;
  • You have access
    Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
    T F Burke, J H Woods, J W Lewis and F Medzihradsky
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 715-721;
  • You have access
    Ethanol decreases the number and activity of splenic natural killer cells in a mouse model for binge drinking.
    W J Wu, R M Wolcott and S B Pruett
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 722-729;
  • You have access
    Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL: inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban.
    N J Lodge
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 730-734;
  • You have access
    Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
    M F O'Rourke, L J Iversen, J W Lomasney and D B Bylund
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 735-740;
  • You have access
    Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
    S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  • You have access
    Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat.
    H M Vargas, L Zhou and A J Gorman
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 748-754;
  • You have access
    Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
    P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
  • You have access
    Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
    E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
  • You have access
    Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
    D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  • You have access
    Tolerance development to the vagal-mediated bradycardia produced by 5-HT1A receptor agonists.
    R B McCall, N A Escandon, L T Harris and M E Clement
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 776-781;
  • You have access
    Effect of potassium channel blockers on relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea.
    J L Ellis and N D Conanan
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 782-786;
  • You have access
    Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
    V P Bakshi, N R Swerdlow and M A Geyer
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 787-794;
  • You have access
    A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
    M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  • You have access
    Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  • You have access
    Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
    B J Undem, S N Meeker and J Chen
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 811-817;
  • You have access
    Effect of interstitial cystitis on drug absorption from urinary bladder.
    X Gao, C A Buffington and J L Au
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 818-823;
  • You have access
    Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
    M R James-Kracke, R B Sexe and S D Shukla
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 824-831;
  • You have access
    Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
    S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;
  • You have access
    In vitro hypoxia attenuates vasorelaxation by potassium channel opening drugs and nitroprusside in isolated pulmonary arteries from rats.
    J C Wanstall
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 845-851;
  • You have access
    Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
    K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  • You have access
    Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
    E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  • You have access
    Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.
    E V Mishina, J Binder, J W Kupiec-Weglinski and W J Jusko
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 868-874;
  • You have access
    Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
    R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  • You have access
    Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
    Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  • You have access
    Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
    C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  • You have access
    Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes.
    T K Machu and R A Harris
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 898-905;
  • You have access
    Functional reconstitution of pharmacologically distinct subtypes of nucleoside transporters in liposomal membranes.
    J R Hammond
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 906-917;
  • You have access
    Nitric oxide (NO) inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: relationship to motility and release of nitric oxide.
    L M Hryhorenko, Z Woskowska and J A Fox-Threlkeld
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 918-926;
  • You have access
    Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
    O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  • You have access
    The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.
    Q Y Liu, E Karpinski and P K Pang
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 935-943;
  • You have access
    L-channel modulation by alpha-1 adrenoceptor activation in neonatal rat ventricular cells: intracellular mechanisms.
    Q Y Liu, E Karpinski and P K Pang
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 944-951;
  • You have access
    Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.
    C B Unal, M D Owen and W R Millington
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 952-958;
  • You have access
    In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    E A Walker, M M Makhay, J D House and A M Young
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 959-968;
  • You have access
    Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
    B Hitzemann, K Dains, S Kanes and R Hitzemann
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 969-976;
  • You have access
    Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
    S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  • You have access
    Attenuation by alpha,beta-methylenadenosine-5'-triphosphate of periarterial nerve stimulation-induced renal vasoconstriction is not due to desensitization of purinergic receptors.
    E Sehic, Y Ruan and K U Malik
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 983-992;
  • You have access
    Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    L R Gerak, E R Butelman, J H Woods and C P France
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 993-999;
  • You have access
    gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.
    J L Goudreau, E J Wagner, K J Lookingland and K E Moore
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1000-1006;
  • You have access
    Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
    G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  • You have access
    Functional subtyping of histamine receptors on the canine proximal colonic mucosa.
    P K Rangachari and T Prior
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1016-1026;
  • You have access
    A diaminoantraquinone inhibitor of angiogenesis.
    S Takano, S Gately, J B Jiang and S Brem
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1027-1033;
  • You have access
    Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
    D D D'Angelo, M G Davis, S Ali and G W Dorn
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1034-1041;
  • You have access
    Pertussis toxin blocks M2 muscarinic receptor-mediated effects on contraction and cyclic AMP in the guinea pig ileum, but not M3-mediated contractions and phosphoinositide hydrolysis.
    E A Thomas and F J Ehlert
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1042-1050;
  • You have access
    Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice.
    S M Roberts, R D Harbison and R C James
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1051-1057;
  • You have access
    Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
    G S Robertson, H Matsumura and H C Fibiger
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1058-1066;
  • You have access
    Over-expression of CYP2C11, the major male-specific form of hepatic cytochrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate.
    N A Pampori and B H Shapiro
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1067-1073;
  • You have access
    Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
    H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;
  • You have access
    In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
    C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  • You have access
    Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
    P M Lacal, A Puglianiello, E Bonmassar and C D'Onofrio
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1086-1095;
  • You have access
    Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
    P M Lacal, C Amici, E Bonmassar and C D'Onofrio
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1096-1102;
  • You have access
    Causes of differential cardiovascular sensitivity to cocaine. II: Sympathetic, metabolic and cardiac effects.
    C A Branch and M M Knuepfer
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1103-1113;
  • You have access
    Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.
    M B Grisham, R D Specian and T E Zimmerman
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1114-1121;
  • You have access
    m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
    M S Grotewiel, H Chu and E Sanders-Bush
    Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1122-1126;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 271, Issue 2
1 Nov 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics